MariMed Inc. (MRMD)
| Market Cap | 30.07M |
| Revenue (ttm) | 157.38M |
| Net Income (ttm) | -17.82M |
| Shares Out | 395.07M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 682,793 |
| Average Volume | 1,449,014 |
| Open | 0.0750 |
| Previous Close | 0.0770 |
| Day's Range | 0.0740 - 0.0823 |
| 52-Week Range | 0.0670 - 0.2300 |
| Beta | 1.00 |
| RSI | 27.93 |
| Earnings Date | Nov 5, 2025 |
About MariMed
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States and internationally. The company sells cannabis flower, vapes, and concentrates under the Nature’s Heritage brand; cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty’s Eddies brand; and cannabis-infused ice creams under Emack & Bolio's brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; cannabis-infused hydrating drink mix for discrete and on-th... [Read more]
Full Company ProfileFinancial Performance
In 2024, MariMed's revenue was $157.96 million, an increase of 6.30% compared to the previous year's $148.60 million. Losses were -$12.16 million, -24.12% less than in 2023.
Financial StatementsNews
MariMed GAAP EPS of -$0.01, revenue of $40.76M misses by $1.39M
MariMed outlines national brand expansion and hemp entry while maintaining positive cash flow
MariMed Inc. (MRMD) Q3 2025 Earnings Call Transcript
MariMed Inc. (OTCQX:MRMD) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Anna Massanari Jon Levine - Co-Founder, CEO, President, Secretary, Treasurer & Director Ryan Crandall ...
MariMed Inc (MRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Industry Challenges
MariMed Inc (MRMD) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Industry Challenges
Q3 2025 MariMed Inc Earnings Call Transcript
Q3 2025 MariMed Inc Earnings Call Transcript
MariMed Inc Reports Q3 EPS of -$0.01, Revenue at $40.8 Million, Missing Estimates
MariMed Inc Reports Q3 EPS of -$0.01, Revenue at $40.8 Million, Missing Estimates
MariMed Reports Third Quarter 2025 Earnings
NORWOOD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, tod...
MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers
NORWOOD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced ma...
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus
MariMed, Xeris Biopharma and Lam Research shine as Zacks' proven stock strategies continue to beat the market despite turmoil.
MariMed's InHouse Brand Again Supports Veterans Facing Housing Challenges With Second Annual Help on the Homefront Campaign
NORWOOD, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- InHouse™ announced today the launch of its second annual Help on the Homefront campaign, a philanthropic effort that provides veterans the chance to w...
MariMed Announces Third Quarter 2025 Earnings Date
MariMed will report its third quarter 2025 financial results on November 5, 2025 and conduct its analyst conference call on November 6, 2025, at 8am ET.
MariMed's Betty's Eddies Spreads Importance of Cancer Screening Education and Awareness through Partnership with Keep A Breast Foundation
NORWOOD, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Betty's Eddies™ announced its third annual collaboration with the Keep A Breast Foundation (“KAB”), furthering its commitment to breast cancer awaren...
MariMed Inc. (MRMD) Q2 2025 Earnings Call Transcript
MariMed Inc. (OTCQX:MRMD) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants Jake Dean - Director of Research and Development Jon R. Levine - Co-Founder, CEO, President, S...
MariMed (MRMD) Q2 EPS Jumps to Positive
MariMed Reports Second Quarter 2025 Earnings
NORWOOD, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, tod...
MariMed Q2 2025 Earnings Preview
MariMed's Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings
NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a ...
MariMed's Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings
NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed," "the Company") (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced ...
CORRECTION -- MariMed Expands Access to Top-Selling Betty's Eddies Brand in Maine
NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”...
MariMed Expands Access to Top-Selling Betty's Eddies Brand in Maine
NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”...
Bullish Sentiment Across The Cannabis Space - Check Full Movers For July 9, 2025
GAINERS: Elixinol Wellness (OTC: ELLXF) shares closed up 490.50% at $0.02 1933 Industries (OTC: TGIFF) shares closed up 45.83% at $0.01 iAnthus Capital Hldgs (OTC: ITHUF) shares closed up 30.77% at...
MariMed Announces Second Quarter 2025 Earnings Date
NORWOOD, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it w...
MariMed Statement Regarding the Commencement of Adult-Use Cannabis Sales in Delaware on August 1st
NORWOOD, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Following today's announcement that Delaware will commence adult-use sales of cannabis, MariMed CEO Jon Levine released the following statement: “We a...
Cannabis Stock Gainers And Losers From May 29, 2025
GAINERS: Rocky Mountain High (OTC: RMHB) shares closed up 36.00% at $0.00 CV Sciences (OTC: CVSI) shares closed up 16.87% at $0.03 MariMed (OTC: MRMD) shares closed up 13.70% at $0.09 Currenc Group...